Anthony H. Ingall

Antagonists of the Platelet P<i>_2T</i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Antithrombotic Therapy, Novel Approach, Pharmacotherapy +17

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 233 citations · Full text

Thrombosis, Platelet Aggregation Inhibitors, Biochemistry +8

Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto‐ATPase

B.E. Crack, C.E. Pollard, Margot W. Beukers et al. · British Journal of Pharmacology · 1995 · 183 citations · Full text

Rabbit Ear Artery, Biochemical Analysis, Fpl 67156 +18

FPL 66096: a novel, highly potent and selective antagonist at human platelet P_2T‐purinoceptors

Robert G. Humphries, Wendy Tomlinson, Anthony H. Ingall et al. · British Journal of Pharmacology · 1994 · 98 citations · Full text

New antiallergic pyrano[3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma

Hugh Cairns, David Cox, Ken J. Gould et al. · Journal of Medicinal Chemistry · 1985 · 91 citations

Asthma, Medicinal Chemistry, Anti-inflammatory +15